Target intelligence / Profile preview

Leucine-rich repeat-containing protein 10 (LRRC10)

Target
LRRC10
Molecular classification
Other (specifically, member of the leucine-rich repeat protein superfamily), Cytoskeletal-associated protein (Z-disc interacting protein)
01

Overview

Leucine-rich repeat-containing protein 10 (LRRC10) is a highly conserved, cardiomyocyte-specific member of the leucine-rich repeat protein superfamily, expressed almost exclusively in heart tissue from early embryonic development through adulthood. LRRC10 localizes strongly to the Z-disc and dyad regions of cardiomyocytes, where it interacts with core contractile proteins like α-actinin and actin to regulate the cytoskeletal architecture crucial for normal cardiac function and excitation-contraction coupling. It is essential for maintaining proper heart muscle contraction, cytoskeletal integrity, and signaling responsive to mechanical stress in the heart. Genetic knockout models lacking LRRC10 develop dilated cardiomyopathy, and human LRRC10 mutations are linked to pediatric and familial idiopathic DCM. LRRC10 is also required for successful cytokinesis in heart muscle cells during development and regeneration, indicating a role in cardiac cell proliferation. No direct pharmacological agents target LRRC10, but its dysfunction has clear implications in inherited and acquired cardiovascular diseases, particularly those involving contractility defects and cardiomyopathy.

Other names
Leucine rich repeat containing 10LRRC10Aheart-restricted leucine-rich repeat proteinHRLRRP
02

Mechanism of action

Not applicable; no drugs directly target LRRC10

03

Biological functions

Regulation of cardiac muscle structure and contractionRegulation of excitation-contraction couplingActs in cytoskeletal organization and mechano-sensingCardiac muscle regeneration and cell cycle control (regulates cytokinesis in cardiomyocytes)
04

Disease associations

Cardiovascular disease (specifically, dilated cardiomyopathy – DCM)
05

Safety considerations

Not applicable (no targeted therapeutics)
06

Interacting drugs

None reported in the literature; no direct drugs known to target LRRC10
07

Biomarkers

Mutations in LRRC10 may serve as genetic biomarkers for susceptibility to idiopathic dilated cardiomyopathy in humans

Beyond the preview

Go deeper on Leucine-rich repeat-containing protein 10 (LRRC10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat-containing protein 10 (LRRC10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call